Results 121 to 130 of about 320,412 (378)
Thoracic Cancer, Volume 14, Issue 2, Page 177-185, January 2023., 2023 This study investigated whether radiomic features extracted from radial‐probe endobronchial ultrasound (radial EBUS) images can assist in decision‐making for subsequent clinical management in cases with indeterminate pathologic results. We demonstrated a radiomics‐added, malignancy prediction model that can categorize lesions with nondiagnostic lung ...
Jihwan Choi +7 more
wiley +1 more source
Determinants Analysis of Pulmonary Tuberculosis Incidence in Tugo Mulyo Primary Care in 2011/2012 [PDF]
, 2013 Background: Pulmonary Tuberculosis is an infectious disease that\u27s caused by Tuberculosis Mycobacteria that primarily attacks the lungs, lymph nodes, and intestines.
Mukholipah, S. (Siti) +2 more
core
Chronic Diseases and Translational Medicine, EarlyView.Flow chart of the study implementation. ABSTRACT Background Computer‐aided detection (CAD) software has been introduced to automatically interpret digital chest X‐rays. This study aimed to evaluate the performance of CAD software (JF CXR‐1 v3.0, which was developed by a domestic Hi‐tech enterprise) in tuberculosis (TB) case finding in China. Methods In
Xuefang Cao +12 more
wiley +1 more source
Hubungan antara Perilaku Ibu dan Lingkungan Fisik Rumah dengan Kejadian Tuberkulosis Paru Anak di Kota Pekalongan [PDF]
, 2015 Background: Children's Tuberculosis (TB) in Indonesia at 2013 was fourth ranks in the world. The cases of children's pulmonary tuberculosis in Pekalongan at 2013 be amounted 88 (32%) of the total cases of TB (271), greater than 8% of national cases ...
Adi, M. S. (M) +2 more
core
ChemMedChem, Accepted Article.Tuberculosis (TB) is the leading cause of death among infectious diseases, and new studies focusing new anti‐TB drugs are urgent due to the emergence of drug‐resistant strains. In this regard, homoisoflavones, an underexplored subgroup of flavonoids, were explored for their potential as anti‐TB agents.
Sanderson D. Calixto +12 more
wiley +1 more source
Assessment of treatment response in tuberculosis [PDF]
, 2016 Antibiotic treatment of tuberculosis has a duration of several months. There is significant variability of the host immune response and the pharmacokinetic-pharmacodynamic properties of Mycobacterium tuberculosis sub-populations at the site of disease. A
Du Bruyn, E +3 more
core +1 more source
CURABILITY OF PULMONARY TUBERCULOSIS. [PDF]
Journal of the American Medical Association, 1897 ABSTRACT Evidence has been recently accumulating, which goes to show that tuberculosis is not only a universal but the universal disease. Postmortem examinations made in recent years, point to the probability that 25 per cent. is much too low an estimate of the total number of infections.Schlenker made one hundred consecutive postmortem examinations on
openaire +3 more sources
Clinical Pharmacology in Drug Development, EarlyView.Abstract This study (NCT04537715) investigated itraconazole (strong cytochrome P450 [CYP] 3A inhibitor) and rifampin (strong CYP3A inducer) on tazemetostat pharmacokinetics. In Part 1, patients received tazemetostat 400 mg orally on Days 1, 15, and 36, and 400 mg twice daily on Days 3‐14 and Days 21‐35.
Yingxue Chen +6 more
wiley +1 more source
International Journal of Infectious Diseases, 2021 Objective: To evaluate he diagnostic performance of the Xpert Mycobacterium tuberculosis/Rifampin (MTB/RIF) assay in bronchoalveolar lavage fluid (BALF).
Juan Yang +9 more
doaj
Hubungan Pengetahuan Dengan Efikasi Diri Penderita Tuberkulosis Paru Di Balai Besar Kesehatan Paru Masyarakat Surakarta [PDF]
, 2016 Tuberculosis ( TB ) is a pulmonary infectious diseases that can attack the lungs. Handling of the high prevalence of TB should be taken to control the disease Pulmonary TB , one of which is the treatment. Treatment of pulmonary TB disease carried out for
, Okti Sri Purwanti, S.Kep., M.Kep., Ns., Sp.Kep.M.B. +2 more
core